Please enable JavaScript to continue using this application.

Compare $ANAB vs $TYRA | Chartloom

Compare

$ANAB vs $TYRA

AnaptysBio Inc · Tyra Biosciences Inc

ANAB

AnaptysBio Inc

TYRA

Tyra Biosciences Inc

Compare $ANAB vs $TYRA

Comparing AnaptysBio Inc and Tyra Biosciences Inc

ANABAnaptysBio Inc

TYRATyra Biosciences Inc

ANABAnaptysBio Inc

Market cap

$1.36B

P/E (TTM)

14.99x

Forward P/E (NTM)

16.38x

Forward P/S (NTM)

10.95x

Rev growth (TTM)

92.9%

YTD performance

2.2%

52W performance

44.4%

FCF yield

1.3%

TYRATyra Biosciences Inc

Market cap

$1.19B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-25.6%

52W performance

46.3%

FCF yield

-9.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANAB

TYRA

Detailed metrics comparison

ANAB

AnaptysBio Inc

TYRA

Tyra Biosciences Inc

Market Cap

ANAB$1.36B

TYRA$1.19B

Enterprise Value

ANAB$1.48B

TYRA$1.11B

Price

ANAB$45.95

TYRA$19.94

P/E Ratio

ANAB14.99x

TYRAN/A

P/S Ratio

ANAB5.73x

TYRA0.00x

EV/Sales

ANAB6.24x

TYRA0.00x

EV/EBITDA

ANAB10.83x

TYRA0.00x

P/B Ratio

ANAB137.06x

TYRA3.97x

P/FCF Ratio

ANAB75.37x

TYRAN/A

EV/FCF

ANAB82.17x

TYRA-10.12x

PEG Ratio

ANABN/A

TYRAN/A

Forward P/E (NTM)

ANAB16.38x

TYRAN/A

Forward P/S (NTM)

ANAB10.95x

TYRAN/A

Revenue (TTM)

ANAB$238M

TYRA$0

Revenue Growth (YoY)

ANAB92.9%

TYRAN/A

Forward Rev Growth

ANAB34.7%

TYRA680.8%

Gross Margin (TTM)

ANAB0.0%

TYRA0.0%

Operating Margin (TTM)

ANAB56.4%

TYRA0.0%

EBITDA Margin (TTM)

ANAB56.5%

TYRA0.0%

Net Margin (TTM)

ANAB82.4%

TYRA0.0%

FCF Margin (TTM)

ANAB7.6%

TYRAN/A

Net Income (TTM)

ANAB$196M

TYRA$-149M

FCF (TTM)

ANAB$18M

TYRA$-110M

EPS (TTM)

ANAB$3.07

TYRA-$2.25

ROE (TTM)

ANAB895.0%

TYRA-4639.0%

ROA (TTM)

ANAB57.4%

TYRA-4307.0%

ROIC (TTM)

ANAB63.2%

TYRA-4639.0%

Cash

ANAB$134M

TYRA$74M

Debt

ANAB$256M

TYRA$0

Net Cash/Debt

ANAB$-123M

TYRA$74M

Current Ratio (TTM)

ANAB5.61x

TYRA14.91x

Quick Ratio (TTM)

ANAB5.54x

TYRA14.48x

Debt/Equity (TTM)

ANAB24.23x

TYRA0.00x

Debt/Assets (TTM)

ANAB0.0%

TYRA0.0%

Interest Coverage (TTM)

ANABN/A

TYRAN/A

Net Debt/EBITDA (TTM)

ANAB0.00x

TYRA0.00x

Beta

ANAB0.82

TYRA0.65

52W Performance

ANAB44.4%

TYRA46.3%

YTD Performance

ANAB2.2%

TYRA-25.6%

% from 52W High

ANAB-37.3%

TYRA-50.9%

% from 52W Low

ANAB51.8%

TYRA50.0%

Asset Turnover (TTM)

ANAB0.70x

TYRA0.00x

FCF Yield (TTM)

ANAB1.3%

TYRA-9.3%

Earnings Yield (TTM)

ANAB14.4%

TYRA-12.5%

Dividend Yield (TTM)

ANABN/A

TYRAN/A

Rule of 40

ANAB100.5

TYRA0.0

EV/GP/RG

ANABN/A

TYRAN/A

Ticker research

View ANAB research View TYRA research

Metric	ANAB AnaptysBio Inc	TYRA Tyra Biosciences Inc
Market & Valuation
Market Cap	$1.36B	$1.19B
Enterprise Value	$1.48B	$1.11B
Price	$45.95	$19.94
P/E Ratio	14.99x	N/A
P/S Ratio	5.73x	0.00x
EV/Sales	6.24x	0.00x
EV/EBITDA	10.83x	0.00x
P/B Ratio	137.06x	3.97x
P/FCF Ratio	75.37x	N/A
EV/FCF	82.17x	-10.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	16.38x	N/A
Forward P/S (NTM)	10.95x	N/A
Revenue & Growth
Revenue (TTM)	$238M	$0
Revenue Growth (YoY)	92.9%	N/A
Forward Rev Growth	34.7%	680.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	56.4%	0.0%
EBITDA Margin (TTM)	56.5%	0.0%
Net Margin (TTM)	82.4%	0.0%
FCF Margin (TTM)	7.6%	N/A
Net Income (TTM)	$196M	$-149M
FCF (TTM)	$18M	$-110M
EPS (TTM)	$3.07	-$2.25
ROE (TTM)	895.0%	-4639.0%
ROA (TTM)	57.4%	-4307.0%
ROIC (TTM)	63.2%	-4639.0%
Financial Health
Cash	$134M	$74M
Debt	$256M	$0
Net Cash/Debt	$-123M	$74M
Current Ratio (TTM)	5.61x	14.91x
Quick Ratio (TTM)	5.54x	14.48x
Debt/Equity (TTM)	24.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.82	0.65
52W Performance	44.4%	46.3%
YTD Performance	2.2%	-25.6%
% from 52W High	-37.3%	-50.9%
% from 52W Low	51.8%	50.0%
Efficiency & Yields
Asset Turnover (TTM)	0.70x	0.00x
FCF Yield (TTM)	1.3%	-9.3%
Earnings Yield (TTM)	14.4%	-12.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	100.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANAB research	View TYRA research

Valuation

P/E Ratio

ANAB

14.99x

P/S Ratio

TYRA

0.00x

ANAB

5.73x

EV/FCF

TYRA

-10.12x

ANAB

82.17x

Growth & revenue

Revenue Growth TTM

ANAB

92.9%

Forward Revenue Growth

TYRA

680.8%

ANAB

34.7%

Profitability & performance

Gross Margin

ANAB

0.0%

TYRA

0.0%

ROE

ANAB

895.0%

TYRA

-4639.0%

FCF Yield %

ANAB

1.3%

TYRA

-9.3%

52-Week Performance

TYRA

46.3%

ANAB

44.4%

Detailed metrics comparison

ANAB

AnaptysBio Inc

TYRA

Tyra Biosciences Inc

Market Cap

ANAB$1.36B

TYRA$1.19B

Enterprise Value

ANAB$1.48B

TYRA$1.11B

Price

ANAB$45.95

TYRA$19.94

P/E Ratio

ANAB14.99x

TYRAN/A

P/S Ratio

ANAB5.73x

TYRA0.00x

EV/Sales

ANAB6.24x

TYRA0.00x

EV/EBITDA

ANAB10.83x

TYRA0.00x

P/B Ratio

ANAB137.06x

TYRA3.97x

P/FCF Ratio

ANAB75.37x

TYRAN/A

EV/FCF

ANAB82.17x

TYRA-10.12x

PEG Ratio

ANABN/A

TYRAN/A

Forward P/E (NTM)

ANAB16.38x

TYRAN/A

Forward P/S (NTM)

ANAB10.95x

TYRAN/A

Revenue (TTM)

ANAB$238M

TYRA$0

Revenue Growth (YoY)

ANAB92.9%

TYRAN/A

Forward Rev Growth

ANAB34.7%

TYRA680.8%

Gross Margin (TTM)

ANAB0.0%

TYRA0.0%

Operating Margin (TTM)

ANAB56.4%

TYRA0.0%

EBITDA Margin (TTM)

ANAB56.5%

TYRA0.0%

Net Margin (TTM)

ANAB82.4%

TYRA0.0%

FCF Margin (TTM)

ANAB7.6%

TYRAN/A

Net Income (TTM)

ANAB$196M

TYRA$-149M

FCF (TTM)

ANAB$18M

TYRA$-110M

EPS (TTM)

ANAB$3.07

TYRA-$2.25

ROE (TTM)

ANAB895.0%

TYRA-4639.0%

ROA (TTM)

ANAB57.4%

TYRA-4307.0%

ROIC (TTM)

ANAB63.2%

TYRA-4639.0%

Cash

ANAB$134M

TYRA$74M

Debt

ANAB$256M

TYRA$0

Net Cash/Debt

ANAB$-123M

TYRA$74M

Current Ratio (TTM)

ANAB5.61x

TYRA14.91x

Quick Ratio (TTM)

ANAB5.54x

TYRA14.48x

Debt/Equity (TTM)

ANAB24.23x

TYRA0.00x

Debt/Assets (TTM)

ANAB0.0%

TYRA0.0%

Interest Coverage (TTM)

ANABN/A

TYRAN/A

Net Debt/EBITDA (TTM)

ANAB0.00x

TYRA0.00x

Beta

ANAB0.82

TYRA0.65

52W Performance

ANAB44.4%

TYRA46.3%

YTD Performance

ANAB2.2%

TYRA-25.6%

% from 52W High

ANAB-37.3%

TYRA-50.9%

% from 52W Low

ANAB51.8%

TYRA50.0%

Asset Turnover (TTM)

ANAB0.70x

TYRA0.00x

FCF Yield (TTM)

ANAB1.3%

TYRA-9.3%

Earnings Yield (TTM)

ANAB14.4%

TYRA-12.5%

Dividend Yield (TTM)

ANABN/A

TYRAN/A

Rule of 40

ANAB100.5

TYRA0.0

EV/GP/RG

ANABN/A

TYRAN/A

Ticker research

View ANAB research View TYRA research

Metric	ANAB AnaptysBio Inc	TYRA Tyra Biosciences Inc
Market & Valuation
Market Cap	$1.36B	$1.19B
Enterprise Value	$1.48B	$1.11B
Price	$45.95	$19.94
P/E Ratio	14.99x	N/A
P/S Ratio	5.73x	0.00x
EV/Sales	6.24x	0.00x
EV/EBITDA	10.83x	0.00x
P/B Ratio	137.06x	3.97x
P/FCF Ratio	75.37x	N/A
EV/FCF	82.17x	-10.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	16.38x	N/A
Forward P/S (NTM)	10.95x	N/A
Revenue & Growth
Revenue (TTM)	$238M	$0
Revenue Growth (YoY)	92.9%	N/A
Forward Rev Growth	34.7%	680.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	56.4%	0.0%
EBITDA Margin (TTM)	56.5%	0.0%
Net Margin (TTM)	82.4%	0.0%
FCF Margin (TTM)	7.6%	N/A
Net Income (TTM)	$196M	$-149M
FCF (TTM)	$18M	$-110M
EPS (TTM)	$3.07	-$2.25
ROE (TTM)	895.0%	-4639.0%
ROA (TTM)	57.4%	-4307.0%
ROIC (TTM)	63.2%	-4639.0%
Financial Health
Cash	$134M	$74M
Debt	$256M	$0
Net Cash/Debt	$-123M	$74M
Current Ratio (TTM)	5.61x	14.91x
Quick Ratio (TTM)	5.54x	14.48x
Debt/Equity (TTM)	24.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.82	0.65
52W Performance	44.4%	46.3%
YTD Performance	2.2%	-25.6%
% from 52W High	-37.3%	-50.9%
% from 52W Low	51.8%	50.0%
Efficiency & Yields
Asset Turnover (TTM)	0.70x	0.00x
FCF Yield (TTM)	1.3%	-9.3%
Earnings Yield (TTM)	14.4%	-12.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	100.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANAB research	View TYRA research